Epigenetic targeting may provide new insight to personalized cancer treatment
A recent study led by researchers at the University of California, Merced (Merced, CA, USA) identified a gene and hormone combination that triggers prostate cancer, providing potential epigenetic drug targets for personalized medicine.
Please sign in or register for FREE to view this content
Sign in to EpigenomicsNet
Register to EpigenomicsNet – the epigenetics and epigenomics network
EpigenomicsNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.